SEC Form 4 · accession 0001513162-16-000724
Anixa Biosciences Inc · ANIX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Robert Andrew Berman
Officer — President and CEO · Director
Period of report
Feb 18, 2016
Accepted (ET)
Feb 19, 2016 · 5:24 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000715446
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Options (Right to Buy)F1,F2 | $2.92 | Feb 18, 2016 | A | 200,000 | A | — | Feb 18, 2026 | Common Stock | 200,000 | 200,000 | D |
Explanation of responses
- F1Right-To-Buy, pursuant to the ITUS Corporation 2010 Share Incentive Plan.
- F2The option vests in 36 consecutive monthly installments beginning on March 31, 2016.